NEW YORK, Nov. 17 /PRNewswire/ -- Saatchi & Saatchi Wellness took home the Grand Clio Award and won one of only two Gold Clio Healthcare awards handed out on Friday, November 13th at the inaugural Clio Healthcare Awards.

Need the help of a pill to catch some zzz’s? According to a new study you’re not alone; the use of prescription sleep aids nearly tripled among young adults between 1998 and 2006.

Sanofi-aventis has announced positive results from a new study that showed Ambien CR CIV tablets 12.5mg provided significant improvement in sleep onset, sleep maintenance and total sleep time over eight weeks in patients with co-morbid insomnia and major depressive disorder who were administered a selective serotonin reuptake inhibitor for depression.

BRIDGEWATER, N.J., June 10 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today results from a new study that showed Ambien CR(R) (zolpidem tartrate extended-release) CIV tablets 12.5 mg provided significant improvement in sleep onset, sleep maintenance and total sleep time over 8 weeks in patients with co-morbid insomnia and major depressive disorder (MDD) who were administered a Selective Serotonin Reuptake Inhibitor (SSRI) for depression.

Neurogen Corporation (Nasdaq: NRGN) today updated the status of its later stage clinical portfolio and announced the future focus of its research efforts.